Taiwan In-Vitro Diagnostics Market is predicted to reach USD 1.39 Billion by 2030

According to the study by Next Move Strategy Consulting, the Taiwan In-Vitro Diagnostics Market size is predicted to reach USD 1.39 billion, at a CAGR of 8.4% by 2030.

Request a FREE Sample: https://www.nextmsc.com/taiwan-in-vitro-diagnostics-market/request-sample

The significant rise in the geriatric’s population drives the growth of the in-vitro diagnostics market in the country.

The escalation in the prevalence of diabetes significantly drives the Taiwan in-vitro diagnostics market demand.

The promising players operating in the Taiwan in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.